Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 57Carcinoma, Non-Small-Cell Lung 52Carcinoma, Renal Cell 38Neoplasm Metastasis 21Lung Neoplasms 21Carcinoma, Hepatocellular 21Squamous Cell Carcinoma of Head and Neck 17Neoplasms 17Colorectal Neoplasms 17Stomach Neoplasms 16Carcinoma, Transitional Cell 14Adenocarcinoma Of Esophagus 12Prostatic Neoplasms 11Hodgkin Disease 11Brain Neoplasms 10Urinary Bladder Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Triple Negative Breast Neoplasms 7Skin Neoplasms 7Rectal Neoplasms 7Pancreatic Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Sarcoma 6Colonic Neoplasms 6Clear-cell metastatic renal cell carcinoma 6Carcinoma, Merkel Cell 6Carcinoma, Basal Cell 6Uveal Melanoma 5

Interventions

pembrolizumab 1Vinorelbine 1Surveys and Questionnaires 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Observation 1Nivolumab 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Dexamethasone 1Carboplatin 1Bevacizumab 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Nivolumab × 90 days × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡